Home >
Library >
Federal Prison System
>
Management of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections: Federal Bureau of Prisons Clinical Practice Guidelines
Archival Notice
This item in our library has been archived due to its date. You have reached this
page though a link from a search engine, a different website, or from a bookmark.
You may find the information on this page to be dated or no longer available. We
are keeping it temporarily available only for archival purposes.
Management of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections: Federal Bureau of Prisons Clinical Practice Guidelines
Publication year:
2005
| Cataloged on:
Oct. 31, 2006
ANNOTATION: Recommendations for the prevention, treatment, and containment of methicillin-resistant Staphylococcus aureus infections within Federal correctional facilities are provided. Procedures include: colonization; transmission; screening and surveillance; diagnosis; reporting; treatment; infection control -- primary prevention; infection control -- secondary prevention; outbreak management; inpatient units; MRSA Tracking and Reporting Form; oral antibiotic treatment options for skin or soft tissue MRSA infections; treatment options for serious MRSA infections; evaluation and treatment of skin and soft tissue infections; MRSA Fact Sheet; Correctional Standard Precautions in the General Population; Correctional Contact Precautions in the General Population; Correctional Standard Precautions in the Health Care Setting; Correctional Contact Precautions in the Health Care Setting; Inmate Fact Sheet - General Instructions for Skin Infections; MRSA Containment Guidelines; MRSA Containment Checklist; and Line Listing of Contacts to MRSA Cases form.